Clinical trial
Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than…
NCT00377091 · University of Minnesota, Other · Withdrawn
Key facts
| NCT number | NCT00377091 |
|---|---|
| Title | Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy |
| Official title | Pilot Pharmacoeconomic Evaluation of Fondaparinux Treatment of Pulmonary Embolism (PE) Compared to Treatment With Unfractionated Heparin |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Fondaparinux |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 15, 2006 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: